Cervical cancer remains one of the most serious diseases threatening women’s health. Academics at Yıldız Technical University are working on a promising drug candidate to combat this disease. The initial results obtained from laboratory studies are remarkable. While traditional cancer treatments destroy cancer cells, the methods used can lead to serious side effects. The new drug candidate developed at YTÜ is intended to both effectively eliminate cancer cells and significantly reduce side effects.

Prof. Dr. Mevlüde Canlıca, a faculty member in the Department of Chemistry at Yıldız Technical University, and her team—who are part of the project—have developed an internationally patented active pharmaceutical ingredient that eliminates cervical cancer cells.

Click here to watch the full report on HaberTürk.